AFT Pharmaceuticals
AFT.NZ
#8401
Rank
โ‚ฌ0.18 B
Marketcap
1,78ย โ‚ฌ
Share price
-0.28%
Change (1 day)
14.00%
Change (1 year)

Revenue for AFT Pharmaceuticals (AFT.NZ)

Revenue in 2025: โ‚ฌ99.33 Million

According to AFT Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ99.33 Million. In 2025 the company made a revenue of โ‚ฌ99.33 Million an increase over the revenue in the year 2024 that were of โ‚ฌ99.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AFT Pharmaceuticals from 2016 to 2025

Annual revenue

Year Revenue Change
2025โ‚ฌ99.33 M0.31%
2024โ‚ฌ99.02 M19.03%
2023โ‚ฌ83.19 M8.4%
2022โ‚ฌ76.74 M13.98%
2021โ‚ฌ67.33 M25.69%
2020โ‚ฌ53.57 M8.18%
2019โ‚ฌ49.52 M0.5%
2018โ‚ฌ49.27 M19.09%
2017โ‚ฌ41.37 M9.56%
2016โ‚ฌ37.76 M